GSDME and hepatocellular carcinoma: In HCC, studies that utilized samples from a TCGA database reported a lower overall survival rate for primary liver cancer patients in the high-expression group than that in the low-expression group [35, 37], suggesting that GSDME is associated with a poor prognosis in HCC (Table 1).